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Enzyme-linked immunosorbent assay, Western blot, 
and virus neutralization assays indicated that red colobus 
monkeys in Kibale National Park, western Uganda, had 
antibodies to a virus that was similar, but not identical, to 
known orthopoxviruses. The presence of a novel poxvirus in 
this endangered primate raises public health and conserva-
tion concerns.
T
he virus subfamily Chordopoxviridae contains emerg-
ing pathogens of considerable concern, both because of 
their historic impact on global human health and because of 
their zoonotic potential (1). Although certain poxviruses in 
this subfamily are among the most extensively studied viral 
pathogens (e.g., smallpox, vaccinia), the natural diversity of 
mammalian poxviruses remains poorly characterized. This 
fact is especially true in sub-Saharan Africa, where at least 
1 zoonotic orthopoxvirus (monkeypox) has caused sporad-
ic human outbreaks since 1970 (2), and infected rodents 
exported to the United States caused a highly publicized 
human outbreak in 2003 (3,4). In this study, we describe 
serologic evidence for a previously uncharacterized poxvi-
rus in endangered red colobus monkeys (Procolobus rufo-
mitratus tephrosceles) from Kibale National Park, western 
Uganda (5,6). Our results, based on postadsorption ELISA, 
Western blot, and virus neutralization assays, extend our 
understanding of the host range and diversity of poxviruses 
and raise public health and conservation concerns.
The Study
From June 12 to June 24, 2006, 31 red colobus (13 
males, 18 females, all adult or subadult) were sampled from 
Kibale National Park, western Uganda (5,6). Animals were 
chemically immobilized in the ﬁ  eld by intramuscular injec-
tion of tiletamine/zolezepam (4.6–9.6 mg/kg body weight) 
with 1.0- or 1.5-mL plastic darts with 5/8-inch needles shot 
from a variable-pressure compressed air riﬂ  e. After initial 
darting, animals were given tiletamine/zolezepam or ket-
amine HCl intravenously as needed. Blood samples were 
collected into vacutainers containing sodium-EDTA, plas-
ma was separated in the ﬁ  eld by centrifugation, and sam-
ples were stored in liquid nitrogen for transport to North 
America. Animals were placed in cloth bags to recover 
from anesthesia and were released near trees and vines that 
were easy to climb and within visual range of their social 
groups. All animals appeared healthy at the time of capture. 
Animal protocols were approved by the McGill University 
Animal Care Committee before data collection.
A vaccinia virus (VV) ELISA was used as an initial 
screening test to detect antipoxvirus antibodies. VV-reac-
tive antibodies were detected with horseradish peroxidase 
(HRP)–conjugated polyclonal goat anti–rhesus macaque 
(RM; Macaca mulatta) immunoglobulin (Ig) G (Fc specif-
ic; Nordic Laboratories, Tilsbug, the Netherlands), which 
readily detected antibodies of other primate species, in-
cluding red colobus monkeys and humans. By using this 
approach, samples from 8 (26%) of 31 red colobus plasma 
scored positive (>200 ELISA units [EU]), 21 (68%) of 
31 scored seronegative (<100 EU), and 2 (6%) of 31 had 
equivocal results (100–200 EU) (online Appendix Fig-
ure, available from www.cdc.gov/EID/content/14/5/801-
appG.htm).
Postadsorption ELISA tests (7) were used next to de-
termine the speciﬁ  city of the response to 1 of 3 orthopox-
viruses: VV, monkeypox virus (MPV), or cowpox virus 
(CPV). Plasma samples were tested directly by ELISA or 
preadsorbed (1:30) for 30 minutes at 37°C with VV, MPV, 
or CPV lysate normalized to contain 6 × 108 PFU/mL before 
addition to virus-coated ELISA plates (Figure 1). The post-
adsorption ELISA test allows one to differentiate among 
closely related orthopoxviruses. For instance, VV-speciﬁ  c 
antibodies are best depleted by VV lysate assayed on a VV-
coated ELISA plate (Figure 1, panel A). However, analysis 
of samples from 10 red colobus with detectable anti-VV 
antibody responses (online Appendix Figure) did not show 
a clear pattern following preadsorption with VV, MPV, or 
CPV antigens, which suggests a similar cross-reactivity to 
each of these 3 orthopoxviruses.
Western blot analysis was performed to characterize 
more fully the antipoxvirus response of the red colobus. 
Two micrograms of puriﬁ  ed MPV, VV, and CPV viral pro-
teins were separated by 4%–20% gradient sodium dodecyl 
sulfate–polyacrylamide gel electrophoresis, transferred to 
polyvinylidene diﬂ  uoride membranes (Invitrogen, Carls-
bad, CA, USA), and probed with plasma (1:10,000) before 
addition of HRP-conjugated polyclonal goat antihuman Ig 
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egon, USAG (γ-speciﬁ  c, Jackson Immunolabs, Inc., West Grove, PA, 
USA) and chemiluminescent detection (Pierce SuperSig-
nal West Dura Substrate, Rockville, IL, USA) (Figure 2). 
VV-immune human, MPV-immune human, MVA (modi-
ﬁ  ed vaccinia Ankara)-immune RM and MPV-immune RM 
plasma samples were included as positive controls to iden-
tify banding patterns typically observed in orthopoxvirus-
immune humans and nonhuman primates. Western blot 
analysis proved more sensitive than anti-VV ELISA (on-
line Appendix Figure), with plasma from 30 of 31 red colo-
bus reacting with at least 1 protein band from MPV, VV, or 
CPV. However, unlike the orthopoxvirus-immune human 
and RM controls, samples from red colobus demonstrated 
fewer immunoreactive bands and different immunodomi-
nant banding patterns, suggesting infection with either a 
distantly related orthopoxvirus or a virus from a different 
genus in the Poxviridae family.
Members of the Orthopoxvirus genus elicit cross-neu-
tralizing antibodies against other members of the same ge-
nus. To determine if the red colobus were infected with an 
orthopoxvirus or a more distantly related poxvirus, plaque 
reduction neutralization assays were performed using 100 
PFU of MPV, VV, or CPV. Plasma samples from all 31 red 
colobus were tested, and all exhibited a neutralizing titer 50 
of <20 against MPV, VV, or CPV (data not shown). These 
ﬁ  ndings suggest that although the monkeys were infected 
with a poxvirus with serologic cross-reactivity to VV (on-
line Appendix Figure), lack of a detectable neutralizing an-
tibody response (<20) indicates that the animals may have 
been infected with a poxvirus that is not a member of the 
Orthopoxvirus genus.
Conclusions
Our results provide evidence that red colobus in Kibale 
National Park have been exposed to a previously unchar-
acterized poxvirus. Kibale red colobus may have been ex-
posed to monkeypox or to a “monkeypox-like” virus, but 
we could not conﬁ  rm this with our current serologic tools. 
On the other hand, other poxviruses, such as Tanapox vi-
rus and Yaba monkey tumor virus, have been identiﬁ  ed in 
Africa, and infection by 1 of these poxviruses or a related 
virus cannot be ruled out. Future studies will require opti-
mizing serologic diagnostics against these divergent pox-
viruses (with appropriate positive and negative controls) to 
determine the identity of the poxvirus/poxviruses that have 
infected the red colobus described here. In this light, we 
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Figure 1. Serologic characterization of red colobus to Orthopoxvirus 
antigens. Plasma samples were collected from 31 red colobus, and 
10 samples with detectable antibody responses to vaccinia virus 
(VV) antigens (online Appendix Figure, available from www.cdc.gov/
EID/content/14/5/801-appG.htm) were chosen for further analysis. 
Plasma samples were tested for speciﬁ   city by a postadsorption 
ELISA (7) in which samples were either unadsorbed or preadsorbed 
with monkeypox virus (MPV), vaccinia virus (VV), or cowpox virus 
(CPV) antigens prior to performing an ELISA on A) VV-, B) MPV-, or 
C) CPV-coated ELISA plates. The results obtained by using plasma 
from a VV-immune human study participant (VV human) and a MPV-
immune participant (MPV human) are shown for comparison. The 
dashed line indicates the cut-off value for a seropositive antibody 
response (200 ELISA units). ND, not determined.
Figure 2. Western blot analysis of Orthopoxvirus  (OPV)–reactive 
antibody responses in red colobus. Western blot analysis was 
performed to further characterize humoral immune responses 
against OPV antigens. Puriﬁ  ed monkeypox virus (MPV), vaccinia 
virus (VV), or cowpox virus (CPV) were separated by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis, transferred 
to polyvinylidene diﬂ  uoride membranes, and probed with plasma 
from a VV-immune human, MPV-immune human, MVA-immune 
RM, MPV-immune RM, and 5 representative red colobus. The red 
colobus animal identiﬁ   cation number is shown in the upper left 
corner of each Western blot for comparison with the ELISA data for 
the same sample described in Figure 1.Poxvirus in Red Colobus Monkeys, Uganda
note that tanapox, a zoonosis of suspected primate origin 
(8,9), derives its name from the Tana River, eastern Kenya, 
which supports an isolated population of red colobus close-
ly related to those in Kibale (P. r. rufomitratus) (10,11).
A protracted outbreak of infectious disease occurred 
in Kibale red colobus from 1971 to 1981, where it caused 
a death rate up to nearly 10% in some social groups, ap-
parently killing only adult male monkeys (12). Although 
neither formal clinical data nor biologic samples were col-
lected, descriptions of lesions of affected monkeys suggest-
ed diffuse to multifocal areas of inﬂ  ammation with gray 
mottling and epidermal crusts on the face (most commonly 
the lips), perineum, and inguinum, followed by alopecia 
and impaired locomotion. Monkeys sampled for the pres-
ent study would almost certainly not yet have been born 
during this period, but these observations raise the possibil-
ity that outbreaks of disease at least outwardly consistent 
with poxvirus infection have occurred previously in Kibale 
red colobus.
Poxviruses are known for their potential to cross spe-
cies barriers (1), and red colobus living in small, unpro-
tected forest fragments outside of Kibale National Park 
interact aggressively and at high rates with local persons 
and their domestic animals (13). At the same time, persons 
in rural western Uganda already bear a high incidence of 
pathogens, including HIV (14), which renders a substan-
tial proportion of the population immunocompromised and 
susceptible to opportunistic infections. Recent outbreaks 
of zoonotic poxviruses have not been documented in our 
study area, despite a local and regional healthcare system 
that would most likely have detected such events. How-
ever, the presence of a novel and potentially zoonotic pox-
virus in red colobus should be viewed as a point of concern 
for the future of public health in this region and elsewhere.
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